Authors
Latest:
Compliance and Cost of Biologic Therapies for Rheumatoid ArthritisMedication compliance is associated with lower overall and disease-related healthcare costs in patients with moderate to severe rheumatoid arthritis receiving biologic therapies.
Latest:
Healthcare Costs Associated With Chronic Opioid Use and Fibromayalgia SyndromeWhile fibromyalgia is associated with a small increase in healthcare costs compared with matched controls, chronic opioid use in these patients results in a large increase.
Latest:
Drug Coverage and Decision Making in Medicare Part D EnrolleesThis pharmacy adjudication, prescription fulfillment study demonstrates how a sudden drop of prescription drug coverage has an effect on Medicare Part D patients' prescription decisions.
Latest:
Bringing Out the Best with Less: The Health-System and Integrated Delivery NetworkDepartments of pharmacy in the hospital will be called upon to work within existing budgets while providing additional services such as medication reconciliation and patient education.
Latest:
Trends Associated with Implementing and Lifting a Pregabalin Step Therapy PolicyThis study examined the impact of a pregabalin step therapy policy on utilization and medical costs in Humana’s Medicare and commercial plans.
Latest:
Inside the Community Pharmacy Residency: FAQs and AnswersCommunity pharmacy residencies provide recent graduates with opportunities to gain a wide range of experience.
Latest:
Healthcare Utilization and Costs for Insured Patients With FibromyalgiaFibromyalgia was related to a pattern of initial increase in utilization and costs, followed by a decrease 7 to 12 months after diagnosis.
Latest:
Op-Ed: Why Consumers Should Plan on Paying More for MedicineGood intentions, bad results: A paradox of healthcare regulation.
Latest:
Your Company Receives a Subpoena – What Now?With the growth of civil and criminal litigation, more companies in the health care space are receiving subpoenas commanding them to provide information to a third party.
Latest:
Effectiveness and Costs of Biologics in Veterans With Rheumatoid ArthritisThis study applied a validated algorithm to estimate the effectiveness and costs of the index biologic used by 4696 US veterans with rheumatoid arthritis.
Latest:
The Comparative Value of 3 Electronic Sources of Medication DataCombining medication history information from multiple sources improves the completeness and accuracy of the medication information.
Latest:
Diabetes Apps: Impacting Patients' LivesA new wave of mobile applications encourages disease management on the go.
Latest:
Leveraging Patient Care Services to Optimize Patient Care in RA: A Pharmacist’s OpportunityThis Continuing Education activity is supported by an educational grant from Sandoz Inc.
Latest:
Collaborating for QualityQuality metrics for desired patient outcomes guide the collaborative efforts of the health care team.
Latest:
Enhancing Pharmacy Practice: Accessible and Affordable Continuing Education for TechniciansNew initiatives are tackling historically limited access to free or affordable courses
Latest:
Justice Department Places Increased Scrutiny On Pharmacies, PharmacistsFederal prosecutors are increasingly turning their attention to pharmacies and pharmacists. In this article, we detail some of the recent enforcement efforts, as well as outline some proactive strategies for compliance.
Latest:
Comparative Effectiveness of TNF Blockers in Rheumatoid Arthritis PatientsAmong rheumatoid arthritis patients newly treated with adalimumab, etanercept, or infliximab, lower dose escalation rates and costs were seen with etanercept.
Latest:
Vitamin D Supplementation and Fall Prevention in the ElderlyVitamin D supplementation has been studied as a possible intervention for reducing the risk of falls in elderly patients.
Latest:
Staging Colon Cancer: New Directions and Managed Care ImplicationsIn September 2009, the Pharmacy & Therapeutics Society gathered a study group of 12 managed care medical and pharmacy directors. The objective was to examine the impact that biomarker-based assays could have on the approaches payers and providers use to manage cancer.
Latest:
Flow of Progress: Optimizing Current Treatment Strategies and the Pharmacist's Role in Benign Prostatic HyperplasiaPharmacists can learn about current treatment strategies for the management of benign prostatic hyperplasia, including special considerations in managing comorbidities.
Latest:
Attorney-Client Privilege: What It Covers, What It Doesn’t Cover, and How to Maintain ItGuidelines and tips that can help specialty pharmacies keep communications related to day-to-day operations, contract negotiation, and mergers and acquisitions privileged.
Latest:
Concerns Over Cardiovascular Risk From Treatment With Osteoporotic TherapyData from a new analysis reinforces concerns surrounding the detrimental impact the novel osteoporotic therapy romosozumab can have on cardiovascular health.
Latest:
Self-care Tips for Pharmacists on the FrontlinePharmacists are routinely putting others ahead of themselves and may not be sure how to find time for self-care.
